The Glucose Grail: Raman Spectroscopy vs. Multispectral PPG in 2026

By Rizowan Ahmed (@riz1raj)
Senior Technology Analyst | Covering Enterprise IT, Hardware & Emerging Trends

The Glucose Grail: Why Your Watch Still Can’t Tell You Your Blood Sugar

The non-invasive glucose monitor remains a significant engineering challenge. We are currently navigating the technical limitations of Raman spectroscopy and multispectral PPG. The debate regarding Non-Invasive Continuous Glucose Monitoring (NICGM) centers on whether these technologies can achieve clinical actionability at scale.

The Raman Spectroscopy Bottleneck: Precision at a Price

Raman spectroscopy relies on inelastic scattering of monochromatic light. By measuring the vibrational modes of molecules, it offers a chemical fingerprint. However, hardware constraints remain significant.

The Hardware Reality Check

• Signal-to-Noise Ratio (SNR): Raman signals are inherently weak, often significantly weaker than the excitation source.
• Thermal Management: Maintaining laser stability in a wearable form factor requires thermal management that impacts device size.
• Motion Artifacts: The integration time required for clinical-grade MARD (Mean Absolute Relative Difference) makes Raman sensitive to movement, necessitating stabilization techniques.

While lab-bench Raman systems can achieve high precision, miniaturized versions integrated into prototypes face challenges maintaining accuracy under real-world ambient light conditions. The fundamental trade-off involves balancing device size and power consumption against the spectral resolution required to distinguish glucose from other interstitial fluid components.

Multispectral PPG: The Statistical Shell Game

Multispectral PPG utilizes an array of LEDs to measure changes in light absorption as blood volume pulses through the microvasculature. The challenge is that glucose does not have a unique optical signature in the visible or NIR spectrum that is easily isolated from the noise of fluctuating hemoglobin, oxygen saturation, and skin perfusion.

The Technical Pillars of PPG Glucose Estimation

• SWIR Integration: The use of the 1300nm-1600nm range is utilized to capture the overtone vibrations of the hydroxyl (OH) group.
• Neural Network Inference: PPG glucose monitors rely on on-device inference, such as quantized Transformers or CNNs, to attempt to decouple the glucose signal from confounding variables like skin melanin and hydration levels.
• Sensor Fusion: Models often combine PPG with impedance spectroscopy to normalize for skin-sensor coupling variations.

Multispectral PPG functions as a predictive model, utilizing proxies of glucose-induced changes in vascular elasticity and fluid viscosity rather than direct measurement.

Comparative Analysis: Clinical Benchmarks

Clinical accuracy is often evaluated using the Clarke Error Grid. Neither technology currently achieves universal accuracy in Zone A. The divergence in their failure modes is significant.

Failure Modes

• Raman Failure: Often hardware-centric, where light leakage or laser drift leads to a loss of signal integrity.
• PPG Failure: Often algorithmic, where changes in autonomic nervous system states can impact the ML model's output.

The Verdict: Architecture Over Algorithm

The market is currently bifurcated. Raman spectroscopy remains focused on clinical-grade applications where the cost of the optical bench can be supported. Multispectral PPG is prevalent in the consumer electronics sector, provided manufacturers can address the calibration drift problem inherent in ML-based estimation.

The takeaway for decision-makers is that single-sensor solutions face significant hurdles. Future architectures may rely on hybrid approaches: a low-power PPG array for continuous trend monitoring, intermittently validated by a secondary module to reset the baseline.

---